Asclepius Meditec: Leading Hydrogen Oxygen Therapy Machine Manufacturer

Do You Believe That Water Can Treat Diseases?

There are already over 2800 research papers globally thatprove this to be true！

Unique With Class Ⅲ CFDA/NMPA For Both Home And Hospital Use

NMPA National Medical Device Registration no.:20203080066
NMPA National Medical Device Registration no.:20233081929

The World's Unique Hydrogen-Oxygen Inhaler Approved As a Class Ⅲ Medical Device

Received the 92th China National Innovation Award

the founder of asclepius meditec lin hsin yung

The Story of the Founder of Asclepius

Since 2008, Japan has been the earliest country in the world to introduce hydrogen-rich water as a means of supporting human health, beginning in 2008. Three years later in 2011, a Taiwanese individual who suffered from advanced gastric adenocarcinoma and nasal T-cell lymphoma, became the first to propose that hydrogen–oxygen mixed gas—produced by electrolyzing water (H₂O) into 66% hydrogen and 33% oxygen—could be inhaled using a hydrogen therapy machine to help address cancer and chronic diseases.

This pioneering discovery was made by Mr. Lin Hsin-Yung, founder of Shanghai Asclepius Meditec. Today, Mr. Lin not only continues to lead a healthy and active life, but his discovery of hydrogen-oxygen therapy (the combination of water and organic nutrition) has benefited countless cancer patients and individuals with chronic illnesses worldwide. During the COVID-19 pandemic, in particular, millions relied on this innovation to make it through life-threatening situations.

For over a decade, the Asclepius team has been dedicated to advancing product development and medical research related to hydrogen oxygen devices. To date, the company has secured over 500 global invention patents and published 97 academic papers, 86 of which are indexed in the SCI database. Asclepius remains the only hydrogen therapy machine manufacturer worldwide capable of producing a Class III medical-grade device approved for human inhalation. Our hydrogen–oxygen nebulizer and other hydrogen therapy devices provide a solution that is safe, effective, non-toxic, compact, and exceptionally quiet. The company was granted two medical device licenses by the China National Medical Products Administration in 2020 and 2023, and is on track to obtain EU CE certification in 2026.

Professor Zhong Nanshan, Director of China’s National Center for Respiratory Diseases and Academician of the Chinese Academy of Engineering, commented:“Using water and targeted nutrition to enhance cellular ATP production can improve physical resilience, prevent illness, assist in treatment, and reduce the need for invasive procedures. This is a groundbreaking innovation with the potential to reshape the future of life sciences.”